XGN
Exagen Inc
Price:  
4.23 
USD
Volume:  
55,581.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XGN WACC - Weighted Average Cost of Capital

The WACC of Exagen Inc (XGN) is 7.0%.

The Cost of Equity of Exagen Inc (XGN) is 7.10%.
The Cost of Debt of Exagen Inc (XGN) is 6.65%.

Range Selected
Cost of equity 6.00% - 8.20% 7.10%
Tax rate 0.40% - 0.50% 0.45%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.1% - 8.0% 7.0%
WACC

XGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.47 0.6
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.20%
Tax rate 0.40% 0.50%
Debt/Equity ratio 0.25 0.25
Cost of debt 6.30% 7.00%
After-tax WACC 6.1% 8.0%
Selected WACC 7.0%